SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-270811
Filing Date
2021-09-13
Accepted
2021-09-13 06:37:02
Documents
15
Period of Report
2021-09-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d200766d8k.htm   iXBRL 8-K 37336
2 EX-99.1 d200766dex991.htm EX-99.1 31518
6 GRAPHIC g200766sp2a.jpg GRAPHIC 2029
7 GRAPHIC g200766sp2b.jpg GRAPHIC 3228
  Complete submission text file 0001193125-21-270811.txt   208209

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20210910.xsd EX-101.SCH 2882
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20210910_lab.xml EX-101.LAB 17373
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20210910_pre.xml EX-101.PRE 10946
8 EXTRACTED XBRL INSTANCE DOCUMENT d200766d8k_htm.xml XML 3233
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37553 | Film No.: 211248556
SIC: 2836 Biological Products, (No Diagnostic Substances)